Oramed Pharmaceuticals (ORMP) Enterprise Value (2010 - 2026)
Oramed Pharmaceuticals (ORMP) reported Enterprise Value of -$18.2 million for Q1 2026, up 82.04% on a YoY basis from -$10.0 million in Q1 2025, and up 64.63% quarter-over-quarter from -$51.4 million in Q4 2025.
Oramed Pharmaceuticals (ORMP) Enterprise Value (2010 - 2026) Analysis & Trends
Oramed Pharmaceuticals has reported Enterprise Value for 17 years, with the latest figure at -$18.2 million in Q1 2026.
- For the quarter ending Q1 2026, Enterprise Value rose 82.04% year-over-year to -$18.2 million; the trailing twelve-month figure through Mar 2026 stood at -$18.2 million (up 82.04% YoY), and the FY2025 full-year result was -$51.4 million, up 53.57% from the prior year.
- Enterprise Value for Q1 2026 stood at -$18.2 million, up from -$51.4 million in the prior quarter.
- The five-year high for Enterprise Value was -$8.6 million in Q2 2023, with the low at -$155.0 million in Q3 2022.
- Historically, Enterprise Value has averaged -$84.3 million across 5 years, with a median of -$99.8 million in 2024.
- Annual changes were most pronounced in 2023 — Enterprise Value soared 93.28% — and 2024, when it tumbled 916.65%.
- Oramed Pharmaceuticals' Enterprise Value stood at -$44.9 million in 2022, then tumbled by 134.63% to -$105.3 million in 2023, then declined by 5.09% to -$110.6 million in 2024, then soared by 53.57% to -$51.4 million in 2025, then soared by 64.63% to -$18.2 million in 2026.
- The last three Enterprise Value figures came in at -$18.2 million (Q1 2026), -$51.4 million (Q4 2025), and -$126.6 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | -32.30 Mn |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | -4.14 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | -286.70 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | -2.77 Mn |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | -18.44 Mn |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | -7.20 Mn |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | -7.25 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -584.73 Mn |
| 10 | Oramed Pharmaceuticals | 151.47 Mn | 133.31 Mn | - | -18.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -18.17 Mn |
| Dec 31, 2025 | -51.36 Mn |
| Sep 30, 2025 | -126.65 Mn |
| Jun 30, 2025 | -24.25 Mn |
| Mar 31, 2025 | -101.17 Mn |
| Dec 31, 2024 | -110.62 Mn |
| Sep 30, 2024 | -85.76 Mn |
| Jun 30, 2024 | -87.44 Mn |
| Mar 31, 2024 | -99.78 Mn |
| Dec 31, 2023 | -105.26 Mn |
| Sep 30, 2023 | -126.53 Mn |
| Jun 30, 2023 | -8.60 Mn |
| Mar 31, 2023 | -25.29 Mn |
| Dec 31, 2022 | -44.86 Mn |
| Sep 30, 2022 | -154.98 Mn |
| Jun 30, 2022 | -127.95 Mn |
| Mar 31, 2022 | -134.46 Mn |
| Nov 30, 2021 | -142.43 Mn |
| Aug 31, 2021 | -87.55 Mn |
| May 31, 2021 | -63.55 Mn |